Act for Hope founder Alexander Seyf says cell and gene therapy's next challenge is not proving the science, but building a connected ecosystem that can turn breakthrough treatments into reliable, scalable, and equitable patient access.
Act for Hope founder Alexander Seyf says cell and gene therapy's next challenge is not proving the science, but building a connected ecosystem that can turn breakthrough treatments into reliable, scalable,...
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
Act for Hope founder Alexander Seyf says cell and gene therapy's next challenge is not proving the science, but building a connected ecosystem that can turn breakthrough treatments into reliable, scalable, and equitable patient access.
Open the app view to save this story, compare related coverage, and continue from the same source.